Cargando…
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review
Until now, treatment of primary autoimmune hemolytic anemia of the warm type (wAIHA) is primarily based on immunosuppression. However, many patients do not respond adequately to treatment, and treated patients may develop severe side effects due to uncontrolled, mixed and/or long-lasting immunosuppr...
Autor principal: | Salama, Abdulgabar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678315/ https://www.ncbi.nlm.nih.gov/pubmed/26696797 http://dx.doi.org/10.1159/000438731 |
Ejemplares similares
-
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Autore, Francesco, et al.
Publicado: (2021) -
Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
por: Liu, Bainan, et al.
Publicado: (2013) -
Autoimmune Hemolytic Anemia in the Pediatric Setting
por: Voulgaridou, Aikaterini, et al.
Publicado: (2021) -
Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021) -
Infectious Complications in Autoimmune Hemolytic Anemia
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)